Skip to content

Assessing the effects of autologous conditioned serum (orthokine) on pain intensity, clinical symptoms, quality of life and work productivity in patients with knee osteoarthritis

Assessing the effects of autologous conditioned serum (orthokine) on pain intensity, clinical symptoms, quality of life and work productivity in patients with knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201707046934N3
Enrollment
50
Registered
2017-07-23
Start date
2017-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Gonarthrosis [arthrosis of knee]

Interventions

Orthokine injection 2 ml 4-6 times.
Treatment - Other
Orthokine injection 2 ml 4-6 times

Sponsors

Vice Chancellor for research of Tabriz University of Medical Sciences
Lead Sponsor
Drug applied research center
Collaborator

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 30-80, having knee osteoarthritis grade II-IV according to Kellgren-Lawrence, having moderate to severe knee pain in the past 4 weeks, being interested to participate in the study. Exclusion criteria: history of knee surgery or arthroscopy in the last six months, history of trauma, history of knee injection during the past 3 months (steroids, hyaluronate, PRP, ACS, ACP), having rheumatoid arthritis or other systemic bone or joint diseases, active inflammation of patellofemoral, BMI>30 kg/m2, malignancy, infection, pregnancy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: baseline, weeks 3,6,12,24, 48 and after 2 and 3 year. Method of measurement: NRS.;Clinical symptoms (pain, stiffness, daily function). Timepoint: baseline, weeks 3,6,12,24, 48 and after 2 and 3 year. Method of measurement: WOMAC.;Quality of life. Timepoint: baseline, weeks 3,6,12,24, 48 and after 2 and 3 year. Method of measurement: SF-36.;Work Productivity and Activity Impairment. Timepoint: baseline, weeks 3,6,12,24, 48 and after 2 and 3 year. Method of measurement: WPAI.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSousan Kolahi

Tabriz University of Medical Sciences

susan.kolahi@gmail.com, kolahis@tbzmed.ac.ir+98 41333371217

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026